Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04703920
Title Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center

Her2-receptor negative breast cancer

ovarian serous carcinoma

prostate cancer


Belinostat + Talazoparib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Rogel Cancer Center Recruiting Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from for the field